Drug intelligence / Profile preview

oxythiamine

Development stage
Preclinical
Lead developer
Benfovir
Modality
Small Molecules
Administration
Oral (in Research/animal Studies), Parenteral (in Research/animal Studies)
01

Overview

**Oxythiamine** is a chemical analog of vitamin B1 (thiamine) that functions as a thiamine antagonist and antimetabolite. It is enzymatically converted into oxythiamine pyrophosphate (OTP), which acts as a competitive inhibitor of thiamine pyrophosphate-dependent enzymes, primarily transketolase, pyruvate dehydrogenase complex, and 2-oxoglutarate dehydrogenase complex. Inhibition of these enzymes disrupts essential metabolic pathways such as the pentose phosphate pathway, reducing ribose-5-phosphate and NADPH production, thereby inhibiting nucleotide synthesis and cell proliferation. Oxythiamine exhibits selective antiproliferative and proapoptotic activity in rapidly dividing cells, particularly tumor cells. It is widely used as a research tool for inducing thiamine deficiency, investigating metabolic pathways, and exploring potential antitumor, antimicrobial, antiviral, antiparasitic, and immunomodulatory applications. Currently, its use is mainly experimental and preclinical, with case reports and in vitro/in vivo studies in oncology, infectious disease, and metabolic research[1][3][4][5][6][7][9].

Other names
oxythiaminehydroxythiamin136-16-3
02

Targets

TKT (Transketolase)TKTL1 (Transketolase-like protein 1)PDH (Pyruvate dehydrogenase complex)α-KGDH (Alpha-ketoglutarate dehydrogenase complex)

Beyond the preview

Go deeper on oxythiamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxythiamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call